|
Q2 FY2026
As of Jul 4, 2026
|
Q1 FY2026
As of Apr 4, 2026
|
Q4 FY2025
As of Jan 3, 2026
|
Q3 FY2025
As of Sep 27, 2025
|
Q2 FY2025
As of Jun 28, 2025
|
Q1 FY2025
As of Mar 29, 2025
|
Q4 FY2024
As of Dec 28, 2024
|
Q3 FY2024
As of Sep 28, 2024
|
Q2 FY2024
As of Jun 29, 2024
|
Q1 FY2024
As of Mar 30, 2024
|
Q4 FY2023
As of Dec 30, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jul 1, 2023
|
Q1 FY2023
As of Apr 1, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Oct 1, 2022
|
Q2 FY2022
As of Jul 2, 2022
|
Q1 FY2022
As of Apr 2, 2022
|
Q4 FY2021
As of Jan 1, 2022
|
Q3 FY2021
As of Oct 2, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowances of $5,143 and $5,149 | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property, Plant, and Equipment, net of accumulated depreciation of $184,252 and $173,586 | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Intangible Assets, Net (Notes 1 and 2) | ||||||||||||||||||||
| Goodwill (Notes 1 and 2) | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Current maturities of long-term obligations (Note 5) | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued payroll and employee benefits | ||||||||||||||||||||
| Accrued warranty costs | ||||||||||||||||||||
| Customer deposits | ||||||||||||||||||||
| Advanced billings | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-Term Obligations (Note 5) | ||||||||||||||||||||
| Deferred Income Taxes | ||||||||||||||||||||
| Other Long-Term Liabilities | ||||||||||||||||||||
| Stockholders' Equity: | ||||||||||||||||||||
| Preferred stock, $.01 par value, 5,000,000 shares authorized; none issued | ||||||||||||||||||||
| Common stock, $.01 par value, 150,000,000 shares authorized; 14,624,159 shares issued | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock at cost, 2,815,057 and 2,835,165 shares | ||||||||||||||||||||
| Accumulated other comprehensive items (Note 7) | ||||||||||||||||||||
| Total Kadant Stockholders' Equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity | ||||||||||||||||||||
Loading...
